8-KLeadership ChangesExhibits & Filings

NETFLIX INC 8-K Report, Executive Changes (Sep 18, 2018)

Filed September 18, 2018For Securities:NFLX

Summary

Netflix, Inc. (NFLX) filed an 8-K on September 17, 2018, to announce the appointment of Dr. Mathias Döpfner to its Board of Directors, effective September 18, 2018. Dr. Döpfner will serve as a Class III director. His addition to the board is a significant governance event, indicating the company's ongoing efforts to strengthen its leadership and strategic oversight. As part of his role, Dr. Döpfner will receive stock options under the existing Director Equity Compensation Plan, a standard practice for non-employee directors at Netflix. This compensation structure aligns director interests with shareholder value through equity participation. The company will also enter into an indemnification agreement with Dr. Döpfner, providing standard legal protections for board members. The filing confirms no related party transactions requiring disclosure.

Key Highlights

  • 1Dr. Mathias Döpfner appointed to Netflix Board of Directors, effective September 18, 2018.
  • 2Dr. Döpfner will serve as a Class III director.
  • 3No committee assignments for Dr. Döpfner have been announced yet.
  • 4Dr. Döpfner will receive stock options under the Director Equity Compensation Plan, a standard arrangement.
  • 5Option grants are monthly, fully vested upon grant, and based on a formula involving fair market value.
  • 6Netflix will enter into a standard indemnification agreement with Dr. Döpfner.
  • 7No related party transactions between Netflix and Dr. Döpfner were disclosed.

Frequently Asked Questions

The 8-K filing does not provide specific biographical details or the professional background of Dr. Mathias Döpfner. Investors may need to refer to the referenced press release (Exhibit 99.1) or other public sources for more information on his qualifications and experience.

Dr. Döpfner will receive stock options monthly, as per Netflix's Director Equity Compensation Plan. The number of options granted will be calculated using the formula: $25,000 / (fair market value on the date of grant x 0.40). These options are fully vested upon grant and exercisable at the fair market value on the grant date.

An indemnification agreement is a contract where the company agrees to cover certain legal costs and liabilities that a director or officer might incur as a result of their service to the company, provided they acted in good faith. This is a standard practice to protect directors and officers and is required by Delaware law to the fullest extent permitted.

Based on the 8-K filing, there are no related party transactions between Netflix and Dr. Döpfner that require disclosure under SEC regulations.